Effect of vasotocin on locomotor activity in bullfrogs varies with developmental stage and sex.
Although neurohypophysial peptides are present in many regions of the developing and adult bullfrog (Rana catesbeiana) brain, the function of these peptides remains unclear. To investigate possible behavioral actions, we examined locomotor activity following peptide injection in bullfrogs at various developmental stages. An intraperitoneal (ip) injection of arginine vasotocin (AVT) in tadpoles (stages V, X, or XVII) produced an immediate and dose-dependent inhibition of locomotor activity. On the other hand, AVT stimulated activity when administered ip to juvenile or adult female bullfrogs, but did not influence activity in juvenile or adult males. The minimum effective dose of AVT, when injected directly into the brain of tadpoles, was 100-fold less than that observed when injected ip, suggesting a central nervous system site of action for this peptide. A vasopressin receptor antagonist (d(CH2)5[Tyr(Me)2]AVP administered ip or icv) significantly increased locomotor activity in tadpoles, compared to controls. Oxytocin, vasopressin, and AVP4-9 inhibited activity in tadpoles while mesotocin, des Gly(NH2)AVP, and pressinoic acid had no significant effect. Injection of PGF2 alpha also significantly decreased activity levels in tadpoles. However, pretreatment of tadpoles with indomethacin, a prostaglandin synthesis inhibitor, did not prevent the behavioral effects of AVT, suggesting that prostaglandin synthesis is not required for this response. In summary, AVT influenced locomotor activity in bullfrog tadpoles and female frogs. This effect shifted during development from an inhibitory action in tadpoles to a stimulatory effect in metamorphosed female frogs. The effect of AVT on juvenile and adult frog locomotion was sexually dimorphic, as this peptide altered female behavior but not male behavior.
Boyd
S K
SK
Department of Biological Sciences, University of Notre Dame, Indiana 46556.
D000818:Animals; D001127:Arginine Vasopressin / Q000502:physiology; D001143:Arousal / Q000502:physiology*; D001921:Brain / Q000502:physiology*; D008124:Locomotion / Q000502:physiology; D008675:Metamorphosis, Biological / Q000502:physiology*; D009043:Motor Activity / Q000502:physiology*; D010455:Peptides / Q000502:physiology; D011892:Rana catesbeiana / Q000502:physiology*; D012726:Sexual Behavior, Animal / Q000502:physiology*; D012741:Sexual Maturation / Q000502:physiology; D014668:Vasotocin / Q000502:physiology*; D014882:Water-Electrolyte Balance / Q000502:physiology
D010455:Peptides; D001127:Arginine Vasopressin; D014668:Vasotocin